Navigation Links
Pharma in 2012: Boom or Bust?
Date:3/27/2013

LONDON and BOSTON, March 27, 2013 /PRNewswire/ --

EP Vantage®, EvaluatePharma®'s award-winning editorial team, today released its "2012 Year in Review" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery.

According to the report, Biotech stocks stormed ahead with the NASDAQ Biotechnology Index up 32 percent; valuations not seen since the start of the fiscal crisis. Significant fundraising also occurred in the sector as quarterly data revealed that the final three months of 2012 saw $1.4 billion raised, marking the best quarter since Q4 2009. On the downside, acquisitions and product deal activity remained stubbornly low, especially in Europe.

The report also examines the year's record number of FDA approvals for novel medicines and the impact this has had on R&D productivity. The regulator approved 43 novel biologic or small-molecule agents in 2012, up from 35 in 2011 and 26 in 2010. As for the patent cliff, branded drugs with annual sales of $33.2 billion in 2011 lost patent protection last year, leaving those revenues exposed to cheap generics.

To view the full "2012 Year in Review" report, go to http://www.evaluatepharma.com/EPVReview2012

"If there was one thing that defined 2012 it had to be the return of investors' appetite for risk. We saw this both in the amount of money raised during the year and also the valuations achieved by US biotechs. While there is an argument that the US biotech sector is in danger of becoming overvalued, I think that the green shoots seen in 2012 will continue to grow in 2013. We have al
'/>"/>

SOURCE Evaluate Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
2. PharmaRoth Labs, Inc. Files New Dietary Ingredient Notification with the US Food and Drug Administration (FDA)
3. Pharmaceutical Executive Magazines 2013 Drug "Brand of the Year" Awarded to Leading Merck Diabetes Drug Januvia
4. Pharmaceuticals - Scandinavia Industry Guide
5. Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
6. CVS/pharmacy Launches Innovative New iPad App Featuring a 3D Virtual Store and Digital Pharmacy Experience
7. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
8. Sihuan Pharmaceutical Announces 2012 Annual Results
9. Bio-pharma Internal Communications Groups Evolving for Structure Optimization
10. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, announced today that the first ... 1/2a clinical trial of AGT-181 in patients with ... AGT-181 is an investigational enzyme replacement therapy ... most severe form of MPS I, Hurler syndrome, ...
(Date:9/2/2015)... YORK, Pa. , Sept. 2, 2015 ... and ASX: UNS), a developer, manufacturer and supplier ... response to third-party initiated expressions of interest, the Company,s ... LLC to conduct a review of strategic alternatives to ... to be explored and evaluated during the review process ...
(Date:9/2/2015)... -- According to a new market research ... Radiography, Ultrasound, Computed & Optical Coherence Tomography, MRI, PET/CT ... Neurology) - Global Forecast to 2020", the Global Veterinary ... by 2020 growing at a CAGR of 6.6% during ... 240 Tables and 44 F igures spread through ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Unilife Announces Review of Strategic Alternatives 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5
(Date:9/2/2015)... , ... September 02, 2015 , ... The medical waste ... billion in 2015, at a CAGR of 5.2%. The global medical waste management market ... The treatment and disposal segment is expected to register the highest growth rate in ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... academic partnership has earned international recognition as a premier center for treatment of ... cause sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has ... to help support childhood cancer research. On June 17, 2014, the owners ... , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next ...
(Date:9/2/2015)... ... September 02, 2015 , ... A third party ... action after seeing a significant increase in unlawful tactics used by out-of-network (OON) ... many cases of OON ASCs encouraging members to have elective procedures done at ...
(Date:9/2/2015)... ... 02, 2015 , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) ... negative impact on consumers. It was reported that 33% are paying an average of ... as an extra $100 compared to last year. Among the drugs that saw the ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... commonly used to treat rheumatoid arthritis (RA) and is ... Despite its widespread use, the understanding of its mechanism ... occurs early in the course of RA and is ... levels of MTX to be reached could be useful ...
... More than 3 million people in America,have some form ... doctors and medicine. Treatment can be tough to get, ... and other medical,conditions. This National Epilepsy Awareness Month, Pfizer ... of uninsured men and women get,prescription medicines for free ...
... appear to be similar to insulin, study says , , ... by fat tissues holds promise for people with insulin ... , The hormone, called apelin, significantly lowered blood ... mice, according to a study published in the November ...
... WALTHAM, Mass., Nov. 4 Vericept, the ... intellectual property protection, is,proud to announce the ... Over 100 companies in the healthcare industry ... maintain regulatory compliance with,HIPAA, as well as ...
... monitoring,solutions and services will reshape the diabetic care ... revenues by 2013, according to Parks,Associates, Enhancing Diabetic ... update finds companies like Medtronic, Cardiocom,Diabetech, and Healthways ... to this paradigm shift in diabetic care. They ...
... November 3, 2008 (Baltimore, MD)New research published in the ... medical journal of the American Academy of Neurology, found ... than girls. By examining age-related improvement of motor skills ... Kennedy Krieger Institute in Baltimore, Md. found that girls ...
Cached Medicine News:Health News:Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered 2Health News:Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered 3Health News:Hormone Lowers Glucose Levels in Mice 2Health News:Vericept Announces 100 Customers in Healthcare Industry for Sensitive Data Protection 2Health News:New Technologies and Care Enhancement Models Will Add $1.4 Billion to the Diabetic Care Market in 2013 2Health News:Study finds ADHD affects motor skills of boys more than girls 2
PremierEdge™ Implant Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: